Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.
At StockStory, we dig beneath the surface of price movements to uncover whether a company's fundamentals justify its current valuation or suggest hidden potential. That said, here are three stocks where the skepticism is well-placed and some better opportunities to consider.
Parsons (PSN)
One-Month Return: -8.7%
Delivering aerospace technology during the Cold War-era, Parsons (NYSE: PSN) offers engineering, construction, and cybersecurity solutions for the infrastructure and defense sectors.
Why Are We Cautious About PSN?
- Estimated sales growth of 5.1% for the next 12 months implies demand will slow from its two-year trend
- Subpar operating margin of 5.5% constrains its ability to invest in process improvements or effectively respond to new competitive threats
- Underwhelming 6.8% return on capital reflects management’s difficulties in finding profitable growth opportunities
Parsons’s stock price of $57.12 implies a valuation ratio of 17.2x forward P/E. Dive into our free research report to see why there are better opportunities than PSN.
Dave & Buster's (PLAY)
One-Month Return: -11.9%
Founded by a former game parlor and bar operator, Dave & Buster’s (NASDAQ: PLAY) operates a chain of arcades providing immersive entertainment experiences.
Why Do We Pass on PLAY?
- Poor same-store sales performance over the past two years indicates it’s having trouble bringing new shoppers into its stores
- Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions
- Depletion of cash reserves could lead to a fundraising event that triggers shareholder dilution
Dave & Buster's is trading at $12.13 per share, or 8.2x forward EV-to-EBITDA. Read our free research report to see why you should think twice about including PLAY in your portfolio.
Avantor (AVTR)
One-Month Return: -2.9%
With roots dating back to 1904 and embedded in virtually every stage of scientific research and production, Avantor (NYSE: AVTR) provides mission-critical products, materials, and services to customers in biopharma, healthcare, education, and advanced technology industries.
Why Is AVTR Risky?
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Sales are projected to be flat over the next 12 months and imply weak demand
- Flat earnings per share over the last five years lagged its peers
At $7.91 per share, Avantor trades at 10x forward P/E. If you’re considering AVTR for your portfolio, see our FREE research report to learn more.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
